Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Journal of Neuroinflammation|December 30, 2017
Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 2017
Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Daniel Boloc, et al.
American Journal of Translational Research|June 9, 2020
Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral bloodTeresa Torres, Daniel Boloc, Natalia Rodríguez, et al.
Anticancer Research|July 28, 2004
Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutationNuria Laso, Sergi Mas, M Jose Lafuente, et al.
Brain, Behavior, and Immunity|July 26, 2019
Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Frontiers in Pharmacology|September 6, 2021
Identification of <i>EP300</i> as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression DataAlbert Martínez-Pinteño, Patricia Gassó, Llucia Prohens, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2026
Polygenic contributions to brain cortical measures, subcortical volumes and hippocampal subfields in first episode psychosisAlex G Segura, Mireia Masias, Laura Julià, et al.
Psychopharmacology|May 9, 2020
Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptomsDaniel Boloc, Natalia Rodríguez, Teresa Torres, et al.
Translational Psychiatry|May 4, 2019
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Journal of Neuroinflammation|December 30, 2017
Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 2017
Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Daniel Boloc, et al.
American Journal of Translational Research|June 9, 2020
Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral bloodTeresa Torres, Daniel Boloc, Natalia Rodríguez, et al.
Anticancer Research|July 28, 2004
Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutationNuria Laso, Sergi Mas, M Jose Lafuente, et al.
Brain, Behavior, and Immunity|July 26, 2019
Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Frontiers in Pharmacology|September 6, 2021
Identification of <i>EP300</i> as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression DataAlbert Martínez-Pinteño, Patricia Gassó, Llucia Prohens, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2026
Polygenic contributions to brain cortical measures, subcortical volumes and hippocampal subfields in first episode psychosisAlex G Segura, Mireia Masias, Laura Julià, et al.
Psychopharmacology|May 9, 2020
Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptomsDaniel Boloc, Natalia Rodríguez, Teresa Torres, et al.
Translational Psychiatry|May 4, 2019
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Pageof 11